Aptamers: A Feasible Technology in Cancer Immunotherapy
Aptamers are single-chained RNA or DNA oligonucleotides (ODNs) with three-dimensional folding structures which allow them to bind to their targets with high specificity. Aptamers normally show affinities comparable to or higher than that of antibodies. They are chemically synthesized and therefore l...
Saved in:
Main Authors: | M. M. Soldevilla, H. Villanueva, F. Pastor |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2016/1083738 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DeepAptamer: Advancing high-affinity aptamer discovery with a hybrid deep learning model
by: Xin Yang, et al.
Published: (2025-03-01) -
Cell-Specific Aptamers as Emerging Therapeutics
by: Cindy Meyer, et al.
Published: (2011-01-01) -
Structure-based insights into fluorogenic RNA aptamers
by: Song Qianqian, et al.
Published: (2024-08-01) -
A new NCL-targeting aptamer-drug conjugate as a promising therapy against esophageal cancer
by: Xue Zheng, et al.
Published: (2025-01-01) -
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
by: Anne Mills, et al.
Published: (2023-06-01)